Sign inJoin waitlistJoin the waitlist

Amitkumar Mehta

Associate Professor · University of Alabama Hospital

Credentials: · · · · ·

History

University of Alabama Hospital
Present
University of Alabama Hospital
Present

Hematology and Medical Oncology
University of Alabama Hospital
2014–2017
Internal Medicine
University of Alabama Hospital
2011–2014
Maharaja Sayajirao University of Baroda / Medical College Baroda
1998–2002

Research

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
The Lancet · 2020 · 2,058 citations
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Blood · 2017 · 206 citations
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019
Journal of the National Comprehensive Cancer Network · 2019 · 135 citations

SB
Stefan Barta
11 papers
Mayur Narkhede
9 papers
Nilanjan Ghosh
9 papers
GS
Guru Sonpavde
8 papers
Reem Karmali
8 papers
Francisco Hernandez-Ilizaliturri
7 papers
Gaurav Goyal
7 papers
Izidore Lossos
7 papers
Jonathon Cohen
7 papers
Julio Chavez
7 papers
Kami Maddocks
7 papers
Manali Kamdar
7 papers

Grants

NCTN Deep South Research Consortium
National Cancer Institute · UG1
PI · $3.7M · University of Alabama at Birmingham
2019–2032
Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $779.5K · University of Alabama at Birmingham
1997–2027
NCTN Deep South Research Consortium
National Cancer Institute · U10
PI · $436.7K · University of Alabama at Birmingham
2014–2019

Clinical trials

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy
Principal investigator · Completed · Phase 2
University of Alabama at Birmingham
2021–2026
Clinical Trial of Ublituximab and Umbralisib With CHOP (U2-CHOP) Followed by U2 Maintenance (U2-CHOP-U2) in Previously Untreated Mantle Cell Lymphoma (MCL)
Principal investigator · Terminated · Phase 1, Phase 2
University of Alabama at Birmingham
2021–2022